Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    50.0%

    Based on 1 completed trials

    Completion Rate
    50%(1/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)
    Terminated
    1(50%)

    Phase Distribution

    Phase 2
    1
    50%
    Phase 4
    1
    50%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    1

    Late Stage

    Phase Distribution2 total trials
    Phase 2Efficacy & side effects
    1(50.0%)
    Phase 4Post-market surveillance
    1(50.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    50.0%

    1 of 2 finished

    Non-Completion Rate

    50.0%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Completed(1)
    Terminated(1)

    Detailed Status

    Completed1
    Terminated1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    50.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 21 (50.0%)
    Phase 41 (50.0%)

    Trials by Status

    completed150%
    terminated150%

    Recent Activity

    0 active trials
    Showing 2 of 2
    terminatedphase_2

    Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)

    NCT02488304
    completedphase_4

    Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI

    NCT02936817

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT02488304Phase 2

    Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)

    Terminated
    NCT02936817Phase 4

    Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Radiation
    Total Trials
    2